BRG1通过破坏PPP2R1A转录来促进B细胞急性淋巴细胞白血病的进展
Qian Kang1,2,3,4, Dan Ma2,4, Peng Zhao1,2,4
1Medical College, Soochow University, Suzhou, 215006, China.
Cell death & disease
|August 26, 2024
概括
布拉玛相关基因1 (BRG1) 的过度表达通过激活关键信号通路,驱动成人B细胞急性淋巴细胞白血病 (B-ALL) 的进展. 向BRG1为改善B-ALL患者的治疗结果提供了一个有希望的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症遗传学 癌症遗传学
背景情况:
- 成年B细胞急性淋巴细胞白血病 (B-ALL) 结局尽管治疗进展,但仍然很差.
- 与Brahma相关的基因1 (BRG1) 被认为是各种癌症的不良预后因素.
- 了解B-ALL分子进展对于开发有效疗法至关重要.
研究的目的:
- 调查BRG1在成人B-ALL病变发生中的作用.
- 阐明BRG1影响B-ALL进展的分子机制.
- 评估BRG1作为B-ALL的治疗点.
主要方法:
- 在B-ALL患者和健康个体中评估BRG1表达水平.
- 操纵BRG1表达,观察细胞周期和细胞亡的影响.
- 研究了BRG1与PPP2R1A基因和PI3K/AKT通路的相互作用.
- 在B-ALL细胞衍生异种移植小鼠模型中利用BRG1沉默和PFI-3抑制剂.
主要成果:
- 成年B-ALL患者的BRG1表达显着更高,与预后不佳相关.
- BRG1上调促进细胞增殖,通过加速细胞循环的进展.
- 降低BRG1的调节会诱导B-ALL细胞的亡.
- BRG1抑制PPP2R1A的表达,激活PI3K/AKT通路,并调节c-Myc和BCL-2.
- 在小鼠模型中,BRG1抑制 (沉默或PFI-3) 抑制了白血病的进展和延长了生存时间.
结论:
- 过度表达BRG1驱动B-ALL通过PPP2R1A/PI3K/AKT信号通路的进展.
- 向BRG1为成人B-ALL.提供了潜在的治疗策略.
- BRG1 是一个重要的分子驱动因子,也是B-ALL的潜在治疗点.
相关概念视频
Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


